Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)
Primary Purpose
Pain Reduction, Function Improvement
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
duloxetine HCL
placebo
Sponsored by

About this trial
This is an interventional treatment trial for Pain Reduction focused on measuring duloxetine, osteoarthritis, pain, function
Eligibility Criteria
Inclusion Criteria:
- primary knee osteoarthritis
Exclusion Criteria:
- inflammatory conditions
- autoimmune disorders
- psychiatric illness
- morbid obesity
Sites / Locations
- Faculty of Medicine, University of Alexandria
Outcomes
Primary Outcome Measures
Pain reduction
Secondary Outcome Measures
Full Information
NCT ID
NCT01425827
First Posted
August 19, 2011
Last Updated
August 27, 2011
Sponsor
University of Alexandria
1. Study Identification
Unique Protocol Identification Number
NCT01425827
Brief Title
Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2011
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alexandria
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Osteoarthritis (OA), a common disabling condition, is the commonest type of arthritis worldwide.Pain is the leading symptom and is often chronic in na. Current treatment options have had limited symptomatic effect and are associated with significant side effects. Duloxetine, a selective serotonin norepinephrine reuptake inhibitor has been demonstrated to have, besides its antidepressant properties, a centrally acting analgesic effect.
The aim of the present study was to investigate the efficacy of duloxetine in reducing pain in older adults with knee OA.
288 patients aged 65 years and above with ACR clinical and radiographic criteria of primary knee OA attending the outpatient clinic of our institution were enrolled in this study. All patients underwent a physical examination and where questioned about the number of flares. Exclusion criteria included any inflammatory, autoimmune, psychiatric illness and morbid obesity. Patients were randomized 1:1. One hundred and forty four received 60mg/day of duloxetine HCL and 144 received placebo together with their usual therapy for 16 weeks. The primary outcome measure was pain reduction. Secondary outcome measures included improvements in physical functioning scores. Pain was assessed using the Brief Pain Inventory (BPI) and Visual Analogue pain Scale, (VAS, 0-100 mm). Functional assessment using the self-reported physical function as measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), WOMAC pain and stiffness scores and the Geriatric Depression Scale (GDS) was conducted. Alterations in dosage of analgesic/NSAID drugs used were recorded. Safety and tolerability were also assessed. Data was collected at baseline and at monthly intervals for 4 months. All staff involved in data collection was blinded to the treatment assignment groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain Reduction, Function Improvement
Keywords
duloxetine, osteoarthritis, pain, function
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
288 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
duloxetine HCL
Intervention Description
60 mg/day duloxetine for 16 weeks
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
similar looking tablets to the active agent for 16 weeks
Primary Outcome Measure Information:
Title
Pain reduction
Time Frame
16 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
primary knee osteoarthritis
Exclusion Criteria:
inflammatory conditions
autoimmune disorders
psychiatric illness
morbid obesity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna Abou-Raya, MD
Organizational Affiliation
University of Alexandria
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Medicine, University of Alexandria
City
Alexandria
ZIP/Postal Code
00203
Country
Egypt
12. IPD Sharing Statement
Citations:
PubMed Identifier
22743149
Citation
Abou-Raya S, Abou-Raya A, Helmii M. Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. Age Ageing. 2012 Sep;41(5):646-52. doi: 10.1093/ageing/afs072. Epub 2012 Jun 27. Erratum In: Age Ageing. 2017 Feb 13;:1.
Results Reference
derived
Learn more about this trial
Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)
We'll reach out to this number within 24 hrs